Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 2.1 Agreement and Plan of Merger
- 3.1 Certificate of Incorporation
- 3.2 Certificate of Amendment to the Certificate of Incorporation
- 3.3 Bylaws
- 4.1 Form of Replacement Warrant
- 4.2 Form of Investor Warrant
- 4.3 Form of Placement Agent Warrant
- 4.4 Registration Rights Agreement
- 4.5 Form of August Investor Warrant
- 4.6 Form of Common Stock Certificate
- 4.7 Form of December 2016 Investor Warrant
- 5.1 Opinion of Lowenstein Sandler
- 10.1 Placement Agency Agreement
- 10.2 Form of Subscription Agreement
- 10.3 Form of Voting Agreement, Dated April 8, 2016, by and Among the Company and the Stockholders Named Therein
- 10.4 2016 Equity Incentive Plan
- 10.5 Form of Incentive Stock Option Agreement
- 10.6 Nonqualified Stock Option Grant Agreement
- 10.7 Restricted Stock Award Agreement
- 10.8 Employment Agreement
- 10.9 Employment Agreement
- 10.10 Subscription Agreement
- 10.11 Promissory Note
- 10.12 Amendment to Promissory Note
- 10.13 Asset Purchase Agreement
- 10.14 Amendment to Asset Purchase Agreement
- 10.15 6% Convertible Note
- 10.16 Amendment to 6% Convertible Note
- 10.17 6% Convertible Note
- 10.18 Amendment to 6% Convertible Note
- 10.19 6% Convertible Note
- 10.20 Amendment to 6% Convertible Note
- 10.21 Engagement Letter
- 10.22 8% Convertible Note
- 10.23 8% Convertible Note
- 10.24 Form of Indemnification Agreement
- 10.25 Employment Agreement
- 10.26 Agreement of Lease
- 10.27 Lease Modification Agreement
- 10.28 Employment Agreement
- 10.29 Amendment No. 1 to Employment Agreement
- 10.30 Amendment No. 1 to Employment Agreement
- 10.31 Amendment No. 1 to Employment Agreement
- 10.32 Amendment No. 1 to Employment Agreement
- 21.1 Subsidiaries of the Registrant
- 23.1 Consents of Experts and Counsel
DMPI similar filings
Filing view
External links
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of Adgero Biopharmaceuticals Holdings, Inc. on Form S-1 of our report dated November 3, 2016 with respect to our audits of the consolidated financial statements of Adgero Biopharmaceuticals Holdings, Inc. as of December 31, 2015 and 2014 and for each of the years then ended, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum llp
Marcum llp
New York, NY
February 14, 2017